Sharenet Sites 
Sharenet Sites
TRADING STATEMENT AND CLARIFICATION OF 30 JUNE 2012 INTERIM RESULTS
CIPLA MEDPRO SOUTH AFRICA LIMITED
(Incorporated in the Republic of South Africa)
(Registration number 2002/018027/06)
(ISIN Number: ZAE000128179 Share Code: CMP)
("Cipla Medpro" or "the Company")
TRADING STATEMENT AND CLARIFICATION OF 30 JUNE 2012 INTERIM RESULTS
In terms of the JSE Limited Listings Requirements, companies are required to publish a trading
statement as soon as they are reasonably certain that the financial results for the current reporting
period will be more than 20% different from those of the previous corresponding period.
Shareholders are advised that the Company expects:
- Normalised EPS and HEPS to increase between 23% and 33% from the 30 June 2011 interim results;
- Actual EPS and HEPS to decrease between 32% and 38% from the 30 June 2011 interim results.
The Company expects earnings per share (“EPS”) and headline earnings per share (“HEPS”) for the
six months ended 30 June 2012 to be between 32% and 38% lower than the EPS and HEPS for the
prior corresponding period due to the items explained below.
The comparative period for the six months ended 30 June 2011 included the pre-tax settlement
income of R68,8 million (2012: Rnil) and unrealised gains on the forward exchange contracts (“FECs”)
of R28,6 million (2012: unrealised loss of R34,2 million). After adjusting for the unrealised loss on the
FECs and the RBSA legal expenses of R10,0 million (2011: Rnil) the normalised EPS and HEPS are
expected to increase between 23% and 33% for the six months ended 30 June 2012. The effect of
the RBSA settlement will only be evident once reviewing the 2012 full year results versus the 2011
full year results.
The information in this trading statement has not been reviewed or reported on by Cipla Medpro's
auditors. The Company's results for the six months ended 30 June 2012 are expected to be published
on or about 16 August 2012.
31 July 2012
Durban
Investment Bank and Sponsor
Nedbank Capital
Date: 31/07/2012 10:30:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
